Pzena Investment Management LLC increased its stake in shares of Cigna Group (NYSE:CI – Free Report) by 1.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 529,841 shares of the health services provider’s stock after buying an additional 6,241 shares during the quarter. Pzena Investment Management LLC’s holdings in Cigna Group were worth $152,727,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also bought and sold shares of the company. CenterBook Partners LP boosted its holdings in Cigna Group by 148.5% during the 3rd quarter. CenterBook Partners LP now owns 4,531 shares of the health services provider’s stock worth $1,306,000 after acquiring an additional 2,708 shares during the last quarter. Essex Financial Services Inc. raised its holdings in shares of Cigna Group by 4.1% in the third quarter. Essex Financial Services Inc. now owns 9,768 shares of the health services provider’s stock valued at $2,816,000 after purchasing an additional 386 shares during the last quarter. King Wealth Management Group increased its stake in Cigna Group by 70.3% in the 3rd quarter. King Wealth Management Group now owns 9,692 shares of the health services provider’s stock valued at $2,794,000 after buying an additional 4,000 shares during the last quarter. Advisors Capital Management LLC increased its stake in Cigna Group by 19.7% in the 3rd quarter. Advisors Capital Management LLC now owns 1,850 shares of the health services provider’s stock valued at $533,000 after buying an additional 305 shares during the last quarter. Finally, First National Bank of Omaha bought a new position in shares of Cigna Group during the 3rd quarter worth approximately $686,000. 86.99% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several research analysts have weighed in on the company. Wall Street Zen raised Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. Robert W. Baird decreased their price objective on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating for the company in a report on Thursday, December 11th. TD Cowen lifted their price objective on shares of Cigna Group from $333.00 to $338.00 and gave the stock a “buy” rating in a research report on Monday, February 9th. Sanford C. Bernstein reissued a “market perform” rating and set a $307.00 target price on shares of Cigna Group in a research report on Tuesday, January 6th. Finally, JPMorgan Chase & Co. reduced their price objective on Cigna Group from $428.00 to $375.00 and set an “overweight” rating for the company in a report on Tuesday, November 4th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, Cigna Group presently has an average rating of “Moderate Buy” and an average price target of $330.63.
Cigna Group Stock Performance
Shares of CI opened at $290.24 on Thursday. Cigna Group has a 52-week low of $239.51 and a 52-week high of $350.00. The stock’s 50-day simple moving average is $278.52 and its 200 day simple moving average is $283.99. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.76 and a current ratio of 0.74. The stock has a market capitalization of $77.53 billion, a price-to-earnings ratio of 13.09, a price-to-earnings-growth ratio of 1.01 and a beta of 0.27.
Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, beating the consensus estimate of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The firm had revenue of $72.50 billion for the quarter, compared to analysts’ expectations of $69.53 billion. During the same period in the prior year, the business posted $6.64 earnings per share. The company’s revenue was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Research analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.
Cigna Group Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be paid a $1.56 dividend. The ex-dividend date is Thursday, March 5th. This represents a $6.24 annualized dividend and a yield of 2.1%. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s dividend payout ratio is currently 27.23%.
Cigna Group Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Featured Articles
- Five stocks we like better than Cigna Group
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- New gold price target
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
